Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMB-2 in CD25+ Cutaneous T-Cell Lymphoma
NCT00080535Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2004
- Primary completion
- Dec 2011
- Modality
- Immunotoxins
- Countries
- 1
01
Overview
A Phase 2 trial of LMB-2 in cutaneous T-cell lymphoma (CTCL), sponsored by National Cancer Institute. Started Apr 2004; status: completed.
02
Drugs
LMB-2
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on NCT00080535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00080535.